Upstream Bio earnings were -$156.5M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest UPB earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$39.7M, down 2.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, UPB reported annual earnings of -$143.4M, with 87.8% growth.
On UPB's earnings call on Aug 12, 2026, Upstream Bio (NASDAQ: UPB) reported Q2 2026 earnings per share (EPS) of -$0.73, up 1.35% year over year. Total UPB earnings for the quarter were -$39.70 million. In the same quarter last year, Upstream Bio's earnings per share (EPS) was -$0.74.
As of the last Upstream Bio earnings report, Upstream Bio is currently losing money. Upstream Bio's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$156.50 million, a 49.8% increase year over year.
What was UPB's earnings growth in the past year?
As of Upstream Bio's earnings date in Aug 12, 2026, Upstream Bio's earnings has grown year over year. UPB earnings in the past year totalled -$156.50 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.